Twist Bioscience Corporation
TWST
$47.66
-$1.98-3.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 391.56M | 376.57M | 362.27M | 347.68M | 330.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 391.56M | 376.57M | 362.27M | 347.68M | 330.19M |
| Cost of Revenue | 189.42M | 185.57M | 183.88M | 185.31M | 182.96M |
| Gross Profit | 202.13M | 191.00M | 178.40M | 162.37M | 147.23M |
| SG&A Expenses | 260.54M | 246.98M | 236.36M | 229.78M | 221.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 526.07M | 512.83M | 504.64M | 503.92M | 493.76M |
| Operating Income | -134.51M | -136.26M | -142.37M | -156.24M | -163.57M |
| Income Before Tax | -75.71M | -76.95M | -84.82M | -190.78M | -196.78M |
| Income Tax Expenses | 876.00K | 720.00K | 367.00K | 367.00K | 537.00K |
| Earnings from Continuing Operations | -76.58 | -77.67 | -85.19 | -191.15 | -197.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.58M | -77.67M | -85.19M | -191.15M | -197.31M |
| EBIT | -134.51M | -136.26M | -142.37M | -156.24M | -163.57M |
| EBITDA | -113.05M | -114.61M | -119.76M | -131.40M | -136.83M |
| EPS Basic | -1.27 | -1.30 | -1.45 | -3.26 | -3.38 |
| Normalized Basic EPS | -1.29 | -1.32 | -1.41 | -1.55 | -1.63 |
| EPS Diluted | -1.28 | -1.31 | -1.46 | -3.26 | -3.39 |
| Normalized Diluted EPS | -1.29 | -1.31 | -1.40 | -1.55 | -1.63 |
| Average Basic Shares Outstanding | 241.15M | 239.23M | 237.36M | 235.51M | 233.64M |
| Average Diluted Shares Outstanding | 242.32M | 240.40M | 238.53M | 235.51M | 233.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |